BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ochi M, Kamoshida T, Ohkawara A, Ohkawara H, Kakinoki N, Hirai S, Yanaka A. Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib. World J Gastroenterol 2018; 24(28): 3155-3162 [PMID: 30065561 DOI: 10.3748/wjg.v24.i28.3155]
URL: https://www.wjgnet.com/1007-9327/full/v24/i28/3155.htm
Number Citing Articles
1
Shou-Sheng Chu, Yu-Hsuan Kuo, Wen-Shan Liu, Shih-Chang Wang, Chung-Han Ho, Yi-Chen Chen, Ching-Chieh Yang, Hung-Chang Wu. Effect of radiotherapy on survival in advanced hepatocellular carcinoma patients treated with sorafenib: a nationwide cancer-registry-based studyScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81176-w
2
Aminah Jatoi, Fang‐Shu Ou, Daniel H. Ahn, Tyler J. Zemla, Jennifer G. Le‐Rademacher, Patrick Boland, Kristen K. Ciombor, Nisha L. Jacobs, Boris Pasche, James M. Cleary, Jeannine S. McCune, Katrina S. Pedersen, Afsaneh Barzi, E. Gabriela Chiorean, Erica N. Heying, Heinz‐Josef Lenz, Jeff A. Sloan, Axel Grothey, Mario E. Lacouture, Tanios Bekaii‐Saab. Preemptive Versus Reactive Topical Clobetasol for Regorafenib‐Induced Hand‐Foot Reactions: A Preplanned Analysis of the ReDOS Trial The Oncologist 2021; 26(7): 610 doi: 10.1002/onco.13730
3
Xuan Qiu, Manjiang Li, Liqun Wu, Yang Xin, Siyu Mu, Tianxiang Li, Kangjian Song. <p>Severe Fatigue is an Important Factor in the Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib</p>Cancer Management and Research 2020; : 7983 doi: 10.2147/CMAR.S233448
4
Álvaro Díaz-González, Marco Sanduzzi-Zamparelli, Víctor Sapena, Ferran Torres, Neus LLarch, Gemma Iserte, Alejandro Forner, Leonardo da Fonseca, José Ríos, Jordi Bruix, María Reig. Systematic review with meta-analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenibAlimentary Pharmacology & Therapeutics 2019; 49(5): 482 doi: 10.1111/apt.15088
5
Masanori Ochi, Toshiro Kamoshida, Masahiro Araki, Tadashi Ikegami. Prolonged survival in patients with hand-foot skin reaction secondary to cooperative sorafenib treatmentWorld Journal of Gastroenterology 2021; 27(32): 5424-5437 doi: 10.3748/wjg.v27.i32.5424
6
Yuka Aimono, Noriko Kohyama, Toshiro Kamoshida, Toshinori Yamamoto, Mari Kogo. QOL Assessment in Chronic Hepatitis C Patients Receiving Ledipasvir/ Sofosbuvir or Simeprevir/Peginterferon/Ribavirin in Clinical PracticeYAKUGAKU ZASSHI 2019; 139(11): 1427 doi: 10.1248/yakushi.19-00019